Medicine and Health Sciences Commons^™

Smoking Cessation Among Persons With Co-Occurring Substance Use Disorder And Mental Illness, Chizimuzo T.C. Okoli, Milan Khara

Chizimuzo T.C. Okoli

Aims: A history of either a substance use disorder (SUD) or psychiatric disorder (PD) is associated with tobacco use. However, there is limited information available on tobacco dependence treatment outcomes among individuals with co-occurring SUD and PD. Methods: Data from 202 participants enrolled in a tobacco dependence treatment program in an outpatient clinic setting were analysed. Findings: In multivariate analysis, having a history of SUD only (OR =.11, 95% CI = .02–.76) and having a co-occurring SUD and PD (OR = .13, 95% CI = .02–.81), as compared to having neither, were significant predictors of a lower likelihood of achieving …

Gender-Specific Profiles Of Tobacco Use Among Non-Institutionalized People With Serious Mental Illness, Joy L. Johnson, Pamela A. Ratner, Leslie A. Malchy, Chizimuzo T.C. Okoli, Ric M. Procyshyn, Joan L. Bottorff, Marlee Groening, Annette Schultz, Marg Osborne

Chizimuzo T.C. Okoli

Background: In many countries, smoking remains the leading preventable cause of death. In North America, reductions in population smoking levels are stabilising and, in recent years, those involved in tobacco control programming have turned their attention to particular segments of society that are at greatest risk for tobacco use. One such group is people with mental illness. A picture of tobacco use patterns among those with mental illness is beginning to emerge; however, there are several unanswered questions. In particular, most studies have been limited to particular in-patient groups. In addition, while it is recognised that men and women differ …

Smoking Cessation Outcomes Among Individuals With Co-Occurring Substance Use Disorder History And Mental Illness, Chizimuzo T.C. Okoli

Chizimuzo T.C. Okoli

BACKGROUND: A history of substance use disorder and/or mental illness is associated with tobacco use. However, there is limited information available on tobacco dependence treatment outcomes in such populations. OBJECTIVES: To examine the effects of a history of substance use disorder and/or mental illness on smoking cessation outcomes. METHODS: Data from 202 participants enrolled in a tobacco treatment program were analyzed. Information on sociodemographics, tobacco use and quit attempt history, social supports for quitting, Fagerstrom Test for Nicotine Dependence scores, importance and confidence in quitting smoking, expired carbon monoxide level, substance use history, mental health history, and previous pharmacotherapy use …

Intensive Tobacco Dependence Treatment For Clients With Substance Use Disorder And/Or Mental Illness, Milan Khara, Chizimuzo T.C. Okoli

Chizimuzo T.C. Okoli

BACKGROUND •Drug treatment populations are disproportionately affected by morbidity and mortality due to tobacco use. However, with appropriately intensive intervention, individuals in drug treatment settings can succeed in their efforts towards smoking cessation. •The Tobacco Dependence Clinic (TDC) is a program that provides smoking cessation counseling and up to 26 weeks of free pharmacotherapy for clients through Vancouver Coastal Health Addiction Services , British Columbia, Canada. There are currently three clinic sites: Pacific Spirit, Three Bridges, and Downtown Community Health Centre (DCHC). •The purpose of this study is to provide 2-year pilot evaluation data (in terms of program completion and …

Assessing Secondhand Tobacco Smoke Exposure Among Persons With Severe And Persistent Mental Illness, Chizimuzo T.C. Okoli, Joy L. Johnson, Leslie Malchy

Chizimuzo T.C. Okoli

Background

• Secondhand tobacco smoke (SHS) exposure increases the risk for cancer, respiratory illness, and cardiovascular disease.

• Individuals with severe and persistent mental illness (SPMI) have a higher smoking prevalence than the general population, placing them at increased risk for related morbidity and mortality.

• Given the higher smoking prevalence in this population, the risk for SHS exposure among smokers and nonsmokers with SPMI should be an issue of concern. Yet, SHS exposure in this population is understudied.

• The purpose of our study was to examine the correlates of SHS exposure in this population. Our specific aims were …